X-155260521-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_171998.4(RAB39B):c.*282G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 370,587 control chromosomes in the GnomAD database, including 9 homozygotes. There are 253 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0071 ( 7 hom., 195 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 2 hom. 58 hem. )
Consequence
RAB39B
NM_171998.4 3_prime_UTR
NM_171998.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.360
Genes affected
RAB39B (HGNC:16499): (RAB39B, member RAS oncogene family) This gene encodes a member of the Rab family of proteins. Rab proteins are small GTPases that are involved in vesicular trafficking. Mutations in this gene are associated with X-linked cognitive disability. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-155260521-C-A is Benign according to our data. Variant chrX-155260521-C-A is described in ClinVar as [Benign]. Clinvar id is 368144.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00708 (790/111591) while in subpopulation AFR AF= 0.0242 (741/30680). AF 95% confidence interval is 0.0227. There are 7 homozygotes in gnomad4. There are 195 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB39B | NM_171998.4 | c.*282G>T | 3_prime_UTR_variant | 2/2 | ENST00000369454.4 | NP_741995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB39B | ENST00000369454.4 | c.*282G>T | 3_prime_UTR_variant | 2/2 | 1 | NM_171998.4 | ENSP00000358466 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00705 AC: 786AN: 111537Hom.: 7 Cov.: 23 AF XY: 0.00572 AC XY: 193AN XY: 33715
GnomAD3 genomes
AF:
AC:
786
AN:
111537
Hom.:
Cov.:
23
AF XY:
AC XY:
193
AN XY:
33715
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00113 AC: 292AN: 258996Hom.: 2 Cov.: 0 AF XY: 0.000789 AC XY: 58AN XY: 73476
GnomAD4 exome
AF:
AC:
292
AN:
258996
Hom.:
Cov.:
0
AF XY:
AC XY:
58
AN XY:
73476
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00708 AC: 790AN: 111591Hom.: 7 Cov.: 23 AF XY: 0.00577 AC XY: 195AN XY: 33779
GnomAD4 genome
AF:
AC:
790
AN:
111591
Hom.:
Cov.:
23
AF XY:
AC XY:
195
AN XY:
33779
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual disability, X-linked 72 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at